In response to an increase in the overall demand for Tamiflu (oseltamivir) and in order to ensure adequate supply for all patients, the manufacturer Hoffmann-La Roche Ltd. has given higher priority to the production of Tamiflu capsules over the powder used for preparing the liquid formulation.